Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

4.850

-0.030 (-0.61%)

At close: Sep 25, 2026, 4:00 PM EDT

4.860

+0.010 (0.21%)

After-hours: Sep 25, 2026, 7:57 PM EDT

Arbutus Biopharma Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	181.72	14.08	6.17	18.14	39.02	10.99
Revenue Growth	1078.78%	128.21%	-65.98%	-53.51%	255.11%	58.92%
Gross Profit	163.92	-11.16	-47.87	-55.56	-45.39	-54.51
Operating Income	147.43	-27.05	-69.97	-78.03	-63.22	-71.65
Net Income	153.05	-33.5	-69.92	-72.85	-69.46	-88.39
Earnings Per Share	0.79	-0.17	-0.38	-0.44	-0.46	-0.83
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	92.63	91.47	122.62	132.29	184.28	191.01
Total Debt	3.63	4.19	6.12	8.72	12.55	18.91
Net Cash (Debt)	89	87.28	116.51	123.57	171.72	172.1
Net Cash Growth	-4.39%	-25.08%	-5.71%	-28.04%	-0.22%	70.85%
Net Cash Per Share	0.46	0.46	0.63	0.74	1.14	1.62

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-24.63	-39.64	-64.85	-85.94	-35.36	-67.53
Capital Expenditures	-	-	-0.18	-1.01	-0.51	-0.81
Free Cash Flow	-24.63	-39.64	-65.03	-86.94	-35.87	-68.34
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	90.20%	-79.23%	-	-	-116.32%	-
Operating Margin	81.13%	-192.08%	-1133.92%	-430.15%	-162.03%	-652.07%
Pretax Margin	84.23%	-237.88%	-1133.04%	-401.57%	-166.62%	-693.91%
Profit Margin	84.23%	-237.88%	-1133.04%	-401.57%	-178.01%	-804.39%
FCF Margin	-13.55%	-281.45%	-1053.83%	-479.27%	-91.92%	-621.96%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	236.87	236.87	236.87	236.87	236.87
PS Ratio	5.28	65.69	100.41	23.11	9.34	47.89